drugset / Trial / NCT02907307

Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis

NCT02907307 ↗

Phase 3 Withdrawn Medinova AG
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy and safety of LactiSal 1%vaginal gel and LactiSal 50 mg vaginal tablet with the standart treatment of clotrimazole 100 mg vaginal tablet in woman with vulvovaginal candidiasis (VVC)

Timeline

Start
2018-12
Primary completion
2019-12
Completion
2020-07

Outcome

Outcome not reported

Stopped: “Development project stopped”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clotrimazole Unknown 100 mg Other